QELBREE 100 mg/1

QELBREE 100 mg extended-release capsules contain viloxazine hydrochloride, a medication used to manage certain mental health conditions. This extended-release formulation is designed to provide consistent levels of the active ingredient over time.

QELBREE is primarily used to address symptoms associated with specific mental health conditions. It is often prescribed to help manage attention deficit hyperactivity disorder (ADHD) in adults. The medication works by affecting certain chemicals in the brain that may be unbalanced in individuals with ADHD. QELBREE is not typically used for immediate relief but rather for long-term management of symptoms.

Common effects of QELBREE may include changes in appetite, sleep disturbances, and mild gastrointestinal discomfort. Some individuals may experience dizziness or headaches, especially when first starting the medication. These effects are generally mild and may diminish as the body adjusts to the medication.

QELBREE should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not crush or chew the extended-release capsules, as this can affect the release of the medication. Always consult a healthcare provider before starting or stopping any medication.

QELBREE may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol should be avoided while taking QELBREE, as it may increase the risk of side effects.